F53ca2be-a290-4157-ad95-d24dfe3344f9-01 (F53ca2be A290 4157 Ad95 D24dfe3344f9 01)
Lansoprazole Capsule, Delayed Release
Product Images NDC 50090-6079
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 50090-6079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
F53ca2be-a290-4157-ad95-d24dfe3344f9-02 (F53ca2be A290 4157 Ad95 D24dfe3344f9 02)
The text describes a graph showing the mean severity of day heartburn for evaluable patients over several days of treatment. The severity is measured on a scale of 0 (none) to 3 (severe). The graph shows the results for a placebo group and two groups taking different dosages of lansoprazole (15 mg and 30 mg). The mean severity of heartburn decreases over time for all three groups, with the groups taking lansoprazole showing lower severity than the placebo group.*
F53ca2be-a290-4157-ad95-d24dfe3344f9-03 (F53ca2be A290 4157 Ad95 D24dfe3344f9 03)
This text provides a chart displaying the mean severity of night heartburn for study days 0 through 50 for patients receiving a placebo, lansoprazole 15 mg QD, and lansoprazole 30 mg QD. The severity is rated on a scale of 0 to 3, with 3 being severe and 0 being none. There is no further information available.*
F53ca2be-a290-4157-ad95-d24dfe3344f9-06 (F53ca2be A290 4157 Ad95 D24dfe3344f9 1)
F53ca2be-a290-4157-ad95-d24dfe3344f9-07 (F53ca2be A290 4157 Ad95 D24dfe3344f9 2)
Label Image (Lbl500906079)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
